businessNewsغير مصنف

Exclusive: J&J discussing breaking up Actelion in an acquisition – sources

(Reuters) – Johnson & Johnson is negotiating a deal to acquire Swiss biotechnology company Actelion Ltd that would separate its commercialized portfolio from its research and development assets, people familiar with the matter said on Thursday.

اظهر المزيد

مقالات ذات صلة

شاهد أيضاً
إغلاق
زر الذهاب إلى الأعلى
إغلاق